Laboratoires Servier, Les

https://www.servier.com

Servier is a global pharmaceutical group governed by a Foundation. Relying on a solid geographical presence and revenue of €4.7 billion in 2020 achieved in 150 countries, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient's voice at the heart of its activities, from research to support beyond the pill. A leader in cardiology, the ambition of the Servier Group is to become a recognized and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neurodegenerative diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies. *

	Start	1954-01-01 established
	Group	Servier (Group)
	Industry	pharmaceutical
	Person	Laureau, Olivier (Servier 201506 President)

	Region	Suresnes
	Country	France
	Street	50 rue Carnot
	City	92284 Suresnes Cedex
	Tel	+33-1-5572-6000
		Address record changed: 2024-01-05

Basic data	Employees	H: 10,001 to 50,00 (2021-01-21)
	Currency	EUR
	Annual sales	4,700,000,000 (revenue, total, consolidated (2020) 2020-12-31)

		* Document for »About Section«: MiNA Therapeutics Ltd.. (1/21/21). "Press Release: Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases". Paris & London.

		Record changed: 2024-02-12